Ying Wang

7.4k total citations
304 papers, 4.6k citations indexed

About

Ying Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ying Wang has authored 304 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 72 papers in Pulmonary and Respiratory Medicine and 60 papers in Oncology. Recurrent topics in Ying Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Virus-based gene therapy research (19 papers) and MicroRNA in disease regulation (18 papers). Ying Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Virus-based gene therapy research (19 papers) and MicroRNA in disease regulation (18 papers). Ying Wang collaborates with scholars based in China, United States and United Kingdom. Ying Wang's co-authors include Sjur Humerfelt, Fredrik A. Dahl, Apurva Jain, Qijun Qian, Knut Stavem, Milind Javle, Daniel H. Ahn, Ping Wang, Yunjing Zhang and Xue‐Ying He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Ying Wang

286 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Wang China 35 1.8k 974 946 836 714 304 4.6k
Haitao Wang China 37 2.2k 1.2× 888 0.9× 679 0.7× 1.0k 1.2× 370 0.5× 337 5.2k
Bernd Wullich Germany 41 2.3k 1.3× 1.3k 1.3× 1.5k 1.6× 1.0k 1.2× 1.3k 1.9× 297 5.5k
Yan Xu China 36 1.7k 0.9× 742 0.8× 1.8k 1.9× 1.8k 2.1× 536 0.8× 432 5.9k
Qiang Ding China 42 3.0k 1.6× 1.3k 1.3× 1.5k 1.6× 816 1.0× 413 0.6× 196 7.0k
Ke Zhang China 39 3.0k 1.6× 1.2k 1.2× 824 0.9× 959 1.1× 237 0.3× 255 6.0k
Andrew H. Fischer United States 34 2.8k 1.5× 601 0.6× 466 0.5× 1.2k 1.4× 768 1.1× 107 6.4k
Yan Lü China 31 1.5k 0.8× 777 0.8× 463 0.5× 432 0.5× 453 0.6× 228 4.2k
He Wang China 47 3.9k 2.1× 1.5k 1.5× 717 0.8× 1.1k 1.3× 1.3k 1.8× 313 8.4k
Mengyuan Li China 32 1.9k 1.0× 799 0.8× 789 0.8× 1.1k 1.3× 268 0.4× 219 5.5k
Zhiqiang Hu China 36 2.1k 1.1× 1.1k 1.1× 462 0.5× 1.1k 1.3× 419 0.6× 166 5.1k

Countries citing papers authored by Ying Wang

Since Specialization
Citations

This map shows the geographic impact of Ying Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Wang more than expected).

Fields of papers citing papers by Ying Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Wang. The network helps show where Ying Wang may publish in the future.

Co-authorship network of co-authors of Ying Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Wang. A scholar is included among the top collaborators of Ying Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Wang. Ying Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chenjun, Jiawen Zhu, Xiaoyang Zhao, et al.. (2025). ViMIC 2.0: an updated database of human disease-related viral mutations, integration sites, and multi-omics data. Nucleic Acids Research. 54(D1). D892–D901. 1 indexed citations
2.
Pan, Zhendong, Liangliang Jiang, Yingying Chen, et al.. (2025). Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations. Journal of Virology. 99(10). e0109925–e0109925.
3.
Wang, Haoren, Yuntao Liu, Kaiqi Liu, et al.. (2025). Clinical features and treatment response to TKIs in chronic myeloid leukemia patients with atypical BCR::ABL1 transcripts. Leukemia Research. 155. 107733–107733. 1 indexed citations
4.
Wang, Ying, Jingying Nong, Mingming Hu, et al.. (2024). Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients. SHILAP Revista de lepidopterología. 4(4). 335–345. 1 indexed citations
5.
Gao, Shuang, et al.. (2024). Hybrid fault diagnosis method for underwater thrusters based on the common features of multi-source signals. Mechanical Systems and Signal Processing. 222. 111740–111740. 4 indexed citations
6.
Xiao, Meng, et al.. (2024). A literature review of a meta-analysis of BRAF mutations in non-small cell lung cancer. Medicine. 103(8). e34654–e34654. 1 indexed citations
7.
Fang, Meng, et al.. (2024). Influence of Environmental Factors and Genome Diversity on Cumulative COVID-19 Cases in the Highland Region of China: Comparative Correlational Study. SHILAP Revista de lepidopterología. 13. e43585–e43585. 1 indexed citations
8.
Wang, Ying, et al.. (2023). The Study on Prognosis in Patients with Adenoid Cystic Carcinoma of the External Auditory Canal. The Journal of International Advanced Otology. 19(2). 149–154. 1 indexed citations
9.
Zhang, Jinlong, Xue Wang, Zhe Zhang, et al.. (2023). Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial. Infectious Diseases and Therapy. 12(12). 2757–2769. 1 indexed citations
10.
Dong, Yi, Dagmar Schreiber-Dietrich, S. Schwarz, et al.. (2023). Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part I. Diagnostics. 13(23). 3568–3568. 3 indexed citations
11.
Ye, Yanyan, et al.. (2023). Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection. BMC Gastroenterology. 23(1). 320–320. 5 indexed citations
12.
13.
14.
Wang, Ying, Zeyu Zhang, Rongbin Zheng, et al.. (2021). ViMIC: a database of human disease-related virus mutations, integration sites and cis -effects. Nucleic Acids Research. 50(D1). D918–D927. 23 indexed citations
15.
Cai, Chao, Zezhen Liu, Xiangkun Wu, et al.. (2021). Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer. Genetic Testing and Molecular Biomarkers. 25(2). 131–139. 8 indexed citations
16.
Wang, Qing, et al.. (2017). [Threshold Segmentation of Pulmonary Subsolid Nodules on CT Images:
Detection and Quantification of the Solid Component].. SHILAP Revista de lepidopterología. 20(5). 341–345. 1 indexed citations
17.
Lu, Xueguan, et al.. (2015). Clinical Effect of Percutaneous Radiofrequency Ablation for Residual Lung Metastases from Breast Cancer After Systemic Chemotherapy.. PubMed. 25(8). 602–5. 5 indexed citations
18.
Byrnes, Kathleen, et al.. (2014). miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth. Molecular Cancer Research. 12(6). 890–900. 49 indexed citations
19.
Fu, Jie, et al.. (2011). Assessment of the Genetic Diversity and Population Structure of Lotus Cultivars Grown in China by Amplified Fragment Length Polymorphism. Journal of the American Society for Horticultural Science. 136(5). 339–349. 20 indexed citations
20.
Han, Dongfang, et al.. (2003). Effect of 12MCP Treatment on Ethylene Production and Quality Retention of‘Delicious’Apples. Acta Horticulturae Sinica. 30(1). 11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haitao Wang Breakdown of academic impact, for papers by Bernd Wullich Breakdown of academic impact, for papers by Yan Xu Breakdown of academic impact, for papers by Qiang Ding Breakdown of academic impact, for papers by Ke Zhang Breakdown of academic impact, for papers by Andrew H. Fischer Breakdown of academic impact, for papers by Yan Lü Breakdown of academic impact, for papers by He Wang Breakdown of academic impact, for papers by Mengyuan Li Breakdown of academic impact, for papers by Zhiqiang Hu
Rankless by CCL
2026